Japan Facial Injectables Market Insights Forecasts to 2033

• The Japan Facial Injectables Market Size was valued at USD 610.2 Million in 2023
• The Market is Growing at a CAGR of 12.23% from 2023 to 2033
• The Japan Facial Injectables Market Size is Expected to Reach USD 1935.12 Million by 2033

The Japan Facial Injectables Market is Anticipated to Reach USD 1935.12 Million by 2033, growing at a CAGR of 12.23% from 2023 to 2033. 

Market Overview

Injectables used on the face to reduce wrinkles, creases, and other imperfections are known as facial injectables. These injections smooth wrinkles, provide volume back to the face and fill up creases. The cheekbones, lips, chin, nasolabial folds, and forehead can all be treated with them. Depending on the type of filler used and the injection site, the effects may endure for several months or even years. Dermal fillers and botulinum toxin are the two main techniques used in facial injectables. These procedures significantly boost the radiance on face skin and naturally facilitate the skin texture with moisture. Given the rise in demand for facial cosmetics, the industry is expected to experience significant expansion. Also, with the rise in financial independence among the youth, the market is predicted to observe significant consumer expenditure on beauty and cosmetic products.  

Report Coverage

This research report categorizes the market for the Japan facial injectables market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan facial injectables market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan facial injectables market.

Driving Factors

One important reason is the growing older population in Japan. As people get older, they look for non-invasive ways to reduce wrinkles and fine lines, two symptoms of aging. Because face injectables are a minimally invasive option, they are becoming increasingly popular as Japan's population ages and there is a growing need for treatments to address visible signs of aging. Consequently, the demand for facial injectables is fueled by this shift in demographics. Furthermore, the industry is further driven by the growing impact of social media and the ongoing search for young aesthetics. People are turning to injectable treatments as a result of the need to keep a young appearance as they exhibit their appearances online more and more.  

Restraining Factors

One of the main factors preventing this industry from growing more quickly is the high cost of these injectables.

Market Segmentation

The Japan facial injectables market share is classified into type and end-user.

• The hyaluronic acid segment is expected to dominate the Japan facial injectables market during the forecast period.       

Based on the type, the Japan facial injectables market is divided into botulinum toxin, collagen, hyaluronic acid, calcium hydroxylapatite, and poly-l-lactic acid. Among these, the hyaluronic acid segment is expected to dominate the Japan facial injectables market during the forecast period. Improved aesthetic results and increased patient safety are two major advantages of hyaluronic acid, which are expected to drive the segment's growth throughout the projection period.

• The facial line correction segment is expected to hold a significant market share through the forecast period.

The Japan facial injectables market is segmented by end user into facial line correction, lip augmentation, acne scar treatment, and face lift. Among these, the facial line correction segment is expected to hold a significant market share through the forecast period. Crow's feet, forehead lines, frown lines, and marionette lines are just a few of the issues that can be treated with facial line repair. It is a popular choice for both younger people looking for preventive measures and older people attempting to reverse the effects of aging because of its adaptability.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan facial injectables market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Galderma
• Allergan Aesthetics
• Merz Pharma GmbH & Co.
• Sinclair Pharma
• Revance Therapeutics
• Ipsen
• Medytox
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In March 2023, Galderma has announced the release of FACE by GaldermaTM, a cutting-edge augmented reality (AR) aesthetic visualization tool that enables patients and aesthetic experts to see the effects of injectable treatments* during the planning phase, before to the start of treatment.

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Japan Facial Injectables Market based on the below-mentioned segments:

Japan Facial Injectables Market, By Type

• Botulinum Toxin
• Collagen
• Hyaluronic Acid
• Calcium Hydroxylapatite
• Poly-L-lactic Acid

Japan Facial Injectables Market, By End User

• Facial Line Correction
• Lip Augmentation
• Acne Scar Treatment
• Face Lift